Cargando…
A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome
INTRODUCTION: Both Δ(9) Tetrahydrocannabidiol (THC) and cannabidiol (CBD) components of cannabis, have been shown to have anticonvulsant effects. Cannabis oils are used to treat seizures in drug‐resistant epilepsy (DRE). Recent trials provide data on dosing, side effects, and efficacy of CBD, yet th...
Autores principales: | McCoy, Bláthnaid, Wang, Laura, Zak, Maria, Al‐Mehmadi, Sameer, Kabir, Nadia, Alhadid, Kenda, McDonald, Kyla, Zhang, Grace, Sharma, Rohit, Whitney, Robyn, Sinopoli, Katia, Snead, O. Carter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144444/ https://www.ncbi.nlm.nih.gov/pubmed/30250864 http://dx.doi.org/10.1002/acn3.621 |
Ejemplares similares
-
Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
por: Pennypacker, Sarah D., et al.
Publicado: (2022) -
Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022) -
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
por: Oultram, Jackson M. J., et al.
Publicado: (2021) -
Spiders, ladybugs and bees: A case of unusual sensations in a child with cingulate epilepsy
por: Whitney, Robyn, et al.
Publicado: (2017) -
THC and CBD Fingerprinting of an Elite Cannabis Collection from Iran: Quantifying Diversity to Underpin Future Cannabis Breeding
por: Mostafaei Dehnavi, Mahboubeh, et al.
Publicado: (2022)